Pharmaceutical Care for a Case of Pan-drug Resistant Acinetobacter baumannii Pulmonary Infection

VernacularTitle:1例泛耐药鲍曼不动杆菌肺部感染患者的药学监护
Author: Shuang LIU ; Dongyuan WU ; Xue TENG ; Mei DONG
Publication Type:Journal Article
Keywords: Pan-drug resistant Acinetobacter baumannii; Anti-infective therapy; Pharmaceutical care
From: China Pharmacy 2015;(26):3726-3728
CountryChina
Language:Chinese
Abstract: OBJECTIVE:To explore the role of clinical pharmacists in the treatment of pan-drug resistant Acinetobacter bau-mannii infection. METHODS:Clinical pharmacists participated in the treatment for a severe pneumonia case of pan-drug resistant A. baumannii infection. Clinical pharmacists supplied overall pharmaceutical care and suggestions with respects to initial medication scheme evaluation,pathogen judgment,therapy drug selection,ADR disposal,etc.,including anti-infective treatment of moxifloxa-cin 0.4 g,ivgtt,qd+meropenem 0.5 g,ivgtt,q8 h+linezolid 0.6 g,ivgtt,q12 h;anti-pan-drug resistant A. baumannii infection of cefoperazone sodium and sulbactam sodium 3.0 g,ivgtt,q8 h+tigecycline 50 mg,ivgtt,q12 h;liver protection of ademetionine 1, 4-Butanedisulfonate 1.0 g,ivgtt,qd+reduced glutathione 1.8 g,ivgtt,qd. RESULTS:After 25 d treatment,the patient hadn’t been fe-vered,and hemogram and hepatic function index decreased to normal value. CONCLUSIONS:Clinical pharmacist should be en-gage in anti-infective treatment and pharmaceutical care,and provide physicians reasonable medication suggestion so as to promote care rate in the clinic.